Clinical utility of micrornas in exhaled breath condensate as biomarkers for lung cancer

HIGHLIGHTS

  • who: Carlos Pérez-Sánchez et al. from the Department of Medicine, School of Clinical Medicine, Cambridge Biomedical Campus, University of Cambridge, Cambridge , AW, UK have published the research work: Clinical Utility of microRNAs in Exhaled Breath Condensate as Biomarkers for Lung Cancer, in the Journal: (JOURNAL) of 21/Dec/2020
  • what: The authors report for the first time the genome-wide miRNA expression profile in EBC samples from lung cancer patients as proof of concept of their potential clinical utility in the diagnosis, prognosis and management of respiratory diseases (study design is displayed . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?